written on 12.06.2014

Pfizer lost its AstraZeneca bid purely on price, CFO says. What else?


Want to know why the potential Pfizer-AstraZeneca marriage failed? Price, says Pfizer CFO Frank D'Amelio. Stating the obvious, obviously. But in balking at Pfizer's offer, AstraZeneca–and allies in the U.K.–raised plenty of other issues. Emotional issues, for some.